215 related articles for article (PubMed ID: 36099043)
21. Developments in therapies for spondyloarthritis.
Sieper J
Nat Rev Rheumatol; 2012 Apr; 8(5):280-7. PubMed ID: 22487798
[TBL] [Abstract][Full Text] [Related]
22. Advances in pharmacotherapies for axial spondyloarthritis.
Toussirot E
Expert Opin Pharmacother; 2023; 24(13):1439-1448. PubMed ID: 37318776
[TBL] [Abstract][Full Text] [Related]
23. Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices.
Kleinert S; Schuch F; Rapp P; Ronneberger M; Wendler J; Sternad P; Popp F; Bartz-Bazzanella P; von der Decken C; Karberg K; Gauler G; Wurth P; Späthling-Mestekemper S; Kuhn C; Vorbrüggen W; Welcker M
Rheumatol Int; 2024 Apr; 44(4):653-661. PubMed ID: 37805981
[TBL] [Abstract][Full Text] [Related]
24. Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation.
Corbett M; Soares M; Jhuti G; Rice S; Spackman E; Sideris E; Moe-Byrne T; Fox D; Marzo-Ortega H; Kay L; Woolacott N; Palmer S
Health Technol Assess; 2016 Feb; 20(9):1-334, v-vi. PubMed ID: 26847392
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics of axial spondyloarthritis patients in China: results from ChinaSpA, the Chinese Spondyloarthritis Registry.
Su J; Wang R; Duan X; Wang Y; Wu Z; Yang M; Xu J; Fan W; Zhao C; Li Q; Wang X; Zhu J; Wu L; Li M; Zeng X
Clin Exp Rheumatol; 2022 Mar; 40(3):544-550. PubMed ID: 33938794
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Non-radiographic Axial Spondyloarthritis and Ankylosing Spondyltis from a Single Rheumatology Hospital in Morocco.
Akasbi N; Nihad S; Sofia Z; Khadija EK; Taoufik H
Curr Rheumatol Rev; 2020; 16(3):240-244. PubMed ID: 30806321
[TBL] [Abstract][Full Text] [Related]
27. Structural disease modification in axial spondyloarthritis.
Dinneen B; O'Shea F; Gensler L
Best Pract Res Clin Rheumatol; 2023 Sep; 37(3):101898. PubMed ID: 38042689
[TBL] [Abstract][Full Text] [Related]
28. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
Song IH; Weiß A; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Lange E; Freundlich B; Rudwaleit M; Sieper J
Ann Rheum Dis; 2013 Jun; 72(6):823-5. PubMed ID: 23172749
[TBL] [Abstract][Full Text] [Related]
29. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
Wallman JK; Kapetanovic MC; Petersson IF; Geborek P; Kristensen LE
Arthritis Res Ther; 2015 Dec; 17():378. PubMed ID: 26703005
[TBL] [Abstract][Full Text] [Related]
30. Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis.
Sieper J; Hu X; Black CM; Grootscholten K; van den Broek RWM; Kachroo S
Semin Arthritis Rheum; 2017 Jun; 46(6):746-753. PubMed ID: 27855973
[TBL] [Abstract][Full Text] [Related]
31. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA study.
Kishimoto M; Ono K; Fukui S; Kawaai S; Deshpande GA; Yoshida K; Ichikawa N; Kaneko Y; Kawasaki T; Matsui K; Morita M; Tada K; Takizawa N; Tamura N; Taniguchi A; Taniguchi Y; Tsuji S; Okada M; Kobayashi S; Komagata Y; López-Medina C; Molto A; van der Heijde D; Dougados M; Tomita T; Kaname S
RMD Open; 2021 Sep; 7(3):. PubMed ID: 34531305
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients.
Rueda-Gotor J; Ferraz-Amaro I; Genre F; González-Mazón I; Corrales A; Calvo-Rio V; Portilla V; Llorca J; Expósito R; Hernández-Hernández V; Quevedo-Abeledo JC; Rodríguez-Lozano C; Lopez-Medina C; Ladehesa-Pineda ML; Castañeda S; Vicente EF; Fernández-Carballido C; Martínez-Vidal MP; Castro-Corredor D; Anino-Fernández J; Peiteado D; Plasencia-Rodríguez C; García-Vivar ML; Galíndez-Agirregoikoa E; Montes-Perez E; Fernández-Díaz C; Blanco R; González-Gay MÁ
Semin Arthritis Rheum; 2022 Aug; 55():152037. PubMed ID: 35689912
[TBL] [Abstract][Full Text] [Related]
34. Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States.
Zhao SS; Ermann J; Xu C; Lyu H; Tedeschi SK; Liao KP; Yoshida K; Moots RJ; Goodson NJ; Solomon DH
Rheumatology (Oxford); 2019 Nov; 58(11):2025-2030. PubMed ID: 31081033
[TBL] [Abstract][Full Text] [Related]
35. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
Sieper J; van der Heijde D; Dougados M; Mease PJ; Maksymowych WP; Brown MA; Arora V; Pangan AL
Ann Rheum Dis; 2013 Jun; 72(6):815-22. PubMed ID: 22772328
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological management of axial spondyloarthritis in adults.
Toussirot E
Expert Opin Pharmacother; 2019 Aug; 20(12):1483-1491. PubMed ID: 31095430
[No Abstract] [Full Text] [Related]
38. Treatment of axial spondyloarthritis: an update.
Danve A; Deodhar A
Nat Rev Rheumatol; 2022 Apr; 18(4):205-216. PubMed ID: 35273385
[TBL] [Abstract][Full Text] [Related]
39. Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey.
Hunter T; Sandoval D; Booth N; Holdsworth E; Deodhar A
Clin Rheumatol; 2021 Aug; 40(8):3161-3167. PubMed ID: 33611647
[TBL] [Abstract][Full Text] [Related]
40. Non-radiographic axial spondyloarthritis in South America. Burden of disease and differential features with respect to ankylosing spondylitis at time of diagnosis. A comprehensive analysis with a focus on images.
Garcia Salinas R; Jaldin Cespedes R; Gomez RA; Aguerre D; Sommerfleck F
Int J Rheum Dis; 2022 Oct; 25(10):1169-1175. PubMed ID: 35891615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
